Home › Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases
 

Keywords :   


Premarket Biotech Digest: Gilead HIV, Eliquis Trial Errors, Clinical Trial Phases

2015-08-04 07:51:25| Biotech - Topix.net

This may be FDA 101 for some people, but many lay investors may not be aware of the precise details; so I am providing this brief note following the FDA itself. All new drugs and almost all drugs applying for new indications must go through a clinical research where it is tested in human subjects prior to FDA approval.

Tags: trial errors clinical digest

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »